Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Mereo BioPharma in share placement for orphan drug

Country: United Kingdom

Mereo BioPharma Group Plc has announced a private share placement intended to raise £15 million to support development of a treatment for osteogenesis imperfecta, a genetic disorder characterised by bones that break easily.

Read more

BerGenBio issues shares on Oslo Stock Exchange

Country: Norway

The Norwegian oncology developer BerGenBio ASA is making an initial public offering of its shares on the Oslo Stock Exchange in order to support development of a Phase 2 compound targeting three cancer indications.

Read more

Ocrevus approved in US for MS

Country: United States

Read more

FDA approves new PARP inhibitor

Country: United States

Read more

Adaptimmune raises $61.8 million to progress TCR products

Country: United Kingdom

Read more

Novo gets green light for haemopilia B drug

Country: Denmark

Read more

First approved drug for Merkel cell carcinoma

Country: Germany

Read more

Xadago approved to treat Parkinson’s disease in US

Country: Italy

Read more

Cell Medica raises £60 million in Series C round

Country: United Kingdom

Read more

Commentary: Gottlieb tipped as FDA head

Country: United States

Read more

Kite says rolling application to FDA finishes soon

Country: United States

Read more

UCART19 cleared for trial in US

Country: United States

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Targeting the tumour microenvironment

subscribers only

Highlights of the March 2017 MedNous issue

The March 2017 MedNous features:

Latest Mednous cover
  • Research Strategy
    Targeting the tumour microenvironment
    Interview with Michel Detheux
  • Oncology Review
    Immunotherapies start to transform cancer care
    By Bruno Pagliara
  • Company Financing
    Breath Therapeutics scoops up €43.5 million
  • Commentary
    The Trump impact on healthcare M&A
    By Tim Sturgeon and Martin Gouldstone
  • Company News
    ALK-Abelló sets sights on US
  • Regenerative Medicine
    TxCell embraces the CAR

The latest MedNous journal. Subscribe to download.